TW
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

We do not have enough information to identify the Areas of Expertise for this doctor.

          Check Dr. Theodore A. Walters' experience treating your condition:
          About Dr. Theodore A. Walters

          Theodore Walters is a Hematologist Oncology specialist and an Oncologist in Boise, Idaho. Walters has been practicing medicine for over 59 years and. He is licensed to treat patients in Idaho.

          His clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial in the past 15 years.

          Insurance

          MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Theodore A. Walters it is best to call his office and ask if your insurance is accepted.


          Call to see if your plan is accepted.
          Locations
          100 E Idaho St, Boise, ID 83712
          Other Locations
          500 W Fort St, Boise, ID 83702
          Background & Education
          Graduate Institution
          Oregon Health Sciences University School Of Medicine, 1963
          Specialties
          Hematology Oncology
          Oncology
          Licenses
          Internal Medicine in ID
          Hospital Affiliations
          Providence VA Medical Center
          St Lukes Boise Medical Center
          Languages Spoken
          English
          Gender
          Male
          Clinical Research

          Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


          1 Clinical Trials

          A Multicenter, Open-Label Study of Nipent, Cytoxan and Rituxan in Patients With Previously Untreated or Treated Chronic Lymphocytic Leukemia.
          1 Total Publications

          A phase II study of erlotinib as initial treatment for patients with stage IIIB-IV non-small cell lung cancer.

          Save this doctor for later
          Sign Up
          Looking for the best doctor for you?
          Start Here
          Is this your doctor?
          Find a second opinion
          Not sure about your diagnosis?
          Check Your Symptoms
           
           
           
           
          Learn about our expert tiers
          Learn more
          Similar Doctors